Cytokinetics Inc (CYTK)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.82B
Last updated: Nov 17, 2026 at 4:15 PM ET
Cytokinetics Inc (CYTK) Stock Chart
Cytokinetics (CYTK) has a latest price of $51.65 on Nov 17, 2026. Its price fell 22.3% over the past 12 months. The month-end price rose 549.4% over the 10 years through Oct 2026, a compound annual rate of 20.6%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $85.19 in Jun 2026 and its lowest $6.32 in Dec 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CYTK with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CYTK.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 33.6%, and over 6 months it fell 32.4%. The month-end price rose 80.7% over the 3 years through Oct 2026, a compound annual rate of 21.8%.
| Period | Change |
|---|---|
| 1 month | -17.6% |
| 3 months | -33.6% |
| 6 months | -32.4% |
| 12 months | -22.3% |
| 12 months, with dividends | -22.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +80.7% | +21.8% |
| 5 years | +80.4% | +12.5% |
| 10 years | +549.4% | +20.6% |
Price by Year
Its best calendar year was 2021, when the price rose 119.3%, and its weakest was 2024, when it fell 43.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $62.99 | -0.9% |
| 2025 | $63.54 | +35.1% |
| 2024 | $47.04 | -43.7% |
| 2023 | $83.49 | +82.2% |
| 2022 | $45.82 | +0.5% |
| 2021 | $45.58 | +119.3% |
| 2020 | $20.78 | +95.9% |
| 2019 | $10.61 | +67.9% |
| 2018 | $6.32 | -22.5% |
| 2017 | $8.15 | -32.9% |
Trading Range
The price is 18.3% below its 50-day average of $63.25 and 25.9% below its 200-day average of $69.66.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $51.65 | |
| 50-day average | $63.25 | -18.3% |
| 200-day average | $69.66 | -25.9% |
Price Risk
Over 3 years, its largest fall from a peak was 72.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.07 |
| Largest fall, 1 year | -40.8% |
| Largest fall, 3 years | -72.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CYTK
What is CYTK's 1-year price change?
Cytokinetics's price fell 22.3% over the past 12 months. With dividends included, the 12-month total return was -22.3%.
What is CYTK's 5-year price change?
Cytokinetics's month-end price rose 80.4% over the 5 years through Oct 2026, a compound annual rate of 12.5%. These figures leave out dividends.
What is CYTK's beta?
Cytokinetics's 1-year beta against the S&P 500 is 1.07, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 40.8%.
Is the CYTK chart free?
Yes. Advanced Charting for CYTK is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CYTK pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors